Surgery Partners, Inc. (SGRY)
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
$14.26+0.64%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
QuarterlyIQ Insights · SGRY
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenues | 3,366.3 | 3,308.7 | 3,114.3 | 2,743.3 | 2,539.3 | 2,225.1 | 1,860.1 | 1,831.4 | 1,771.5 | — | 1,145.4 | 959.9 |
| Total Revenues | — | — | — | — | — | — | — | — | — | — | 1,145.4 | 959.9 |
| Cost of Revenues | — | — | — | — | — | — | — | 1,407.6 | 1,361.4 | — | 821.2 | 669.3 |
| Operating Expenses & Income | ||||||||||||
| Operating Income | 383.8 | 389.5 | 348.8 | 328.0 | 345.2 | 302.2 | 183.0 | 235.9 | 77.8 | — | 196.5 | 144.8 |
| Earnings from Continuing Operations | ||||||||||||
| Asset Writedown | — | — | — | — | 0.0 | 0.0 | 33.5 | 7.9 | 74.4 | — | — | — |
| Income Tax Expense | 20.5 | 18.0 | 134.6 | (0.3) | 23.3 | 10.5 | (20.1) | 9.5 | 26.4 | — | 7.1 | (149.0) |
| Net Income | ||||||||||||
| Minority Interest | 170.5 | 176.8 | 180.6 | 147.2 | 141.6 | 141.6 | 117.4 | 119.9 | 110.1 | — | 75.6 | 71.4 |
| Net Income | (88.6) | (77.9) | (168.1) | (11.9) | (54.6) | (70.9) | (116.1) | (74.8) | (205.7) | — | 9.5 | 1.4 |
| Per Share | ||||||||||||
| Basic EPS | (0.69) | (0.61) | (1.33) | (0.09) | (0.59) | (1.12) | (3.19) | — | (4.96) | — | 0.20 | 0.04 |
| Diluted EPS | (0.69) | (0.61) | (1.33) | (0.09) | (0.59) | (1.12) | (3.19) | — | (4.96) | — | 0.20 | 0.04 |
| Revenue per Share | 26.13 | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 128.8 | 127.2 | 126.1 | 125.6 | 92.0 | 72.4 | 48.8 | — | 48.0 | — | 48.0 | 36.1 |
| Diluted Weighted Avg Shares | 128.8 | 127.2 | 126.1 | 125.6 | 92.0 | 72.4 | 48.8 | — | 48.0 | — | 48.2 | 37.5 |
| Supplemental | ||||||||||||
| EBITDA | — | 565.5 | 501.4 | 446.1 | 460.0 | 401.0 | 277.8 | 312.4 | 145.2 | — | 236.0 | 179.3 |
| EBIT | 383.8 | 389.5 | 348.8 | 328.0 | 345.2 | 302.2 | 183.0 | 235.9 | 77.8 | — | 196.5 | 144.8 |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.